Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Quarterly Revenue
The quarterly revenue for Labcorp Holdings Inc. (LH) is $3.54B with a period-over-period change of +0.62%. Quarterly revenue is the total sales generated during the latest fiscal quarter.
LH Quarterly Revenue Chart
Quarterly Revenue History
| Date | Quarterly Revenue | % Change |
|---|---|---|
| Q1 2026 | $3.54B | +0.62% |
| Q4 2025 | $3.52B | (1.34%) |
| Q3 2025 | $3.56B | +1.03% |
| Q2 2025 | $3.53B | +5.45% |
| Q1 2025 | $3.35B | +0.47% |
| Q4 2024 | $3.33B | +1.44% |
| Q3 2024 | $3.28B | +1.90% |
| Q2 2024 | $3.22B | +1.39% |
| Q1 2024 | $3.18B | +4.72% |
| Q4 2023 | $3.03B | (0.77%) |
| Q3 2023 | $3.06B | +0.76% |
| Q2 2023 | $3.03B | (0.13%) |
| Q1 2023 | $3.04B | (17.32%) |
| Q4 2022 | $3.67B | +28.16% |
| Q3 2022 | $2.87B | (1.92%) |
| Q2 2022 | $2.92B | (25.04%) |
| Q1 2022 | $3.90B | (3.86%) |
| Q4 2021 | $4.06B | (0.16%) |
| Q3 2021 | $4.06B | +5.78% |
| Q2 2021 | $3.84B | (7.71%) |
| Q1 2021 | $4.16B | (7.31%) |
| Q4 2020 | $4.49B | +15.24% |
| Q3 2020 | $3.90B | +40.71% |
| Q2 2020 | $2.77B | (1.95%) |
| Q1 2020 | $2.82B | (4.39%) |
| Q4 2019 | $2.95B | +0.85% |
| Q3 2019 | $2.93B | +1.62% |
| Q2 2019 | $2.88B | +3.24% |
| Q1 2019 | $2.79B | +0.13% |
| Q4 2018 | $2.79B | (1.55%) |
| Q3 2018 | $2.83B | (1.22%) |
| Q2 2018 | $2.87B | +0.63% |
| Q1 2018 | $2.85B | +1.86% |
| Q4 2017 | $2.80B | +5.31% |
| Q3 2017 | $2.66B | +4.42% |
| Q2 2017 | $2.54B | +3.92% |
| Q1 2017 | $2.45B | +0.77% |
| Q4 2016 | $2.43B | +0.57% |
| Q3 2016 | $2.41B | (0.66%) |
| Q2 2016 | $2.43B | +2.65% |
| Q1 2016 | $2.37B | +2.93% |
| Q4 2015 | $2.30B | (0.72%) |
| Q3 2015 | $2.32B | +2.12% |
| Q2 2015 | $2.27B | +26.54% |
| Q1 2015 | $1.79B | +18.54% |
| Q4 2014 | $1.51B | (2.52%) |
| Q3 2014 | $1.55B | +2.33% |
| Q2 2014 | $1.52B | +5.99% |
| Q1 2014 | $1.43B | (0.44%) |
| Q4 2013 | $1.44B | (1.72%) |
| Q3 2013 | $1.46B | (0.41%) |
| Q2 2013 | $1.47B | +1.89% |
| Q1 2013 | $1.44B | +2.53% |
| Q4 2012 | $1.41B | (0.99%) |
| Q3 2012 | $1.42B | (0.28%) |
| Q2 2012 | $1.42B | +0.01% |
| Q1 2012 | $1.42B | +4.19% |
| Q4 2011 | $1.37B | (2.73%) |
| Q3 2011 | $1.40B | +0.09% |
| Q2 2011 | $1.40B | +2.55% |
| Q1 2011 | $1.37B | +5.64% |
| Q4 2010 | $1.30B | +1.48% |
| Q3 2010 | $1.28B | +3.08% |
| Q2 2010 | $1.24B | +3.75% |
| Q1 2010 | $1.19B | +2.45% |
| Q4 2009 | $1.17B | (1.69%) |
| Q3 2009 | $1.19B | (0.31%) |
| Q2 2009 | $1.19B | +2.86% |
| Q1 2009 | $1.16B | +3.27% |
| Q4 2008 | $1.12B | (1.41%) |
| Q3 2008 | $1.14B | (1.11%) |
| Q2 2008 | $1.15B | +4.04% |
| Q1 2008 | $1.10B | +9.68% |
| Q4 2007 | $1.01B | (1.45%) |
| Q3 2007 | $1.02B | (2.16%) |
| Q2 2007 | $1.04B | +4.45% |
| Q1 2007 | $998.70M | +11.14% |
| Q4 2006 | $898.60M | (1.24%) |
| Q3 2006 | $909.90M | +0.69% |
| Q2 2006 | $903.70M | +2.87% |
| Q1 2006 | $878.50M | +6.83% |
| Q4 2005 | $822.30M | (3.59%) |
| Q3 2005 | $852.90M | (0.05%) |
| Q2 2005 | $853.30M | +6.78% |
| Q1 2005 | $799.10M | +4.25% |
| Q4 2004 | $766.50M | (1.92%) |
| Q3 2004 | $781.50M | (0.36%) |
| Q2 2004 | $784.30M | +4.23% |
| Q1 2004 | $752.50M | +2.87% |
| Q4 2003 | $731.50M | (2.73%) |
| Q3 2003 | $752.00M | +1.12% |
| Q2 2003 | $743.70M | +4.42% |
| Q1 2003 | $712.20M | +9.55% |
| Q4 2002 | $650.10M | (0.78%) |
| Q3 2002 | $655.20M | +6.99% |
| Q2 2002 | $612.40M | - |
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter